Short-Term Outcomes After COVID-19-Related Treatment Interruption Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Bevacizumab

Allegrini D, Raimondi R, Montesano G, Borgia A, Sorrentino T, Tsoutsanis P, Romano MR

Clinical Ophthalmology 2021, 15:4073-4079

Published Date: 8 October 2021